Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 482-120-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: A 28-day repeated dose study vaginal lavages to determine the stage of estrous in females were performed and spermatogenic endpoints (motility/viability, morphology, enumeration of epididymal and testicular sperm and sperm pr... (see attached file)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 407 with vaginal lavages to determine the stage of estrous in females and spermatogenic endpoints (motility/viability, morphology, enumeration of epididymal and testicular sperm and sperm production rates)
- Principles of method if other than guideline:
- A 28-day repeated dose study vaginal lavages to determine the stage of estrous in females were performed and spermatogenic endpoints (motility/viability, morphology, enumeration of epididymal and testicular sperm and sperm production rates) were evaluated.
- GLP compliance:
- yes
- Remarks:
- OECD [C (97) 1 86/Final]
- Limit test:
- no
Test material
- Details on test material:
- - Name of test material (as cited in study report): C-4000
- Physical state: liquid
- Analytical purity: 86.3 +/- 0.7%
- Purity test date: 2008-07-09
- Lot/batch No.: 51V034K7
- Expiration date of the lot/batch: 2008-10
- Storage condition of test material: refrigerated
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina
- Age at study initiation: approx. 8 weeks
- Weight at study initiation: 246 g to 275 g for males; 170 g to 203 g for females
- Fasting period before study:
- Housing: housed individually in clean, wire-mesh cages suspended above cage-board, which were changed at least three times weekly.
- Diet (e.g. ad libitum): PMI Nutrition International, LLC, Certified Rodent LabDiet® 5002; ad libitum
- Water (e.g. ad libitum): Reverse osmosis-treated (on-site) drinking water; ad libitum
- Acclimation period: All animals were housed for a 14-day acclimation/pretest period.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 70.4°F to 70.6°F (21.3°C to 21.5°C)
- Humidity (%): 43.2% to 51.5%
- Air changes (per hr): Air handling units were set to provide a minimum of 10 fresh air changes per hour.
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark photoperiod
IN-LIFE DATES: From: 2008-08-05 To: 2008-09-02 and 03
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: PMI nutrition International, LLC Certified Rodent LabDiet® 5002
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test substancewas added to PMI Nutrition International, LLC Certified Rodent 5002 on a weight/weight
basis and blended in a Hobart blender. The resulting premix was mixed thoroughly with additional PMI Nutrition International, LLC Certified Rodent 5002 in a V-Blender to obtain the appropriate dietary concentrations. Concentrations were prepared from lowest to highest. Test substance dietary admixtures will be corrected for test substance purity (correction factor of 1.159)
DIET PREPARATION
- Rate of preparation of diet (frequency): The control and test diets were prepared approximately weekly
- Mixing appropriate amounts with (Type of food): PMI nutrition International, LLC Certified Rodent LabDiet® 5002
- Storage temperature of food: placed in labeled storage bags and stored at room temperature
VEHICLE
- Justification for use and choice of vehicle (if other than water): feed in dietary study
- Concentration in vehicle: ranged from 93.2% of nominal to 107% of nominal - Details on mating procedure:
- While no mating was done in this study, the assessment of multiple parameters are clearly relevant to the evaluation of reproductive organ capacity.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- In the present study, diet formulations prepared at target concentrations of 300, 1000 and 10,000 ppm C-4000 were evaluated for test substance concentration acceptability.
The analyzed formulations used for test substance administration met the WIL standard operating procedure requirements for concentration acceptability for diet admix formulations, i.e., the analyzed concentrations were 85% to 115% of the target concentrations. Chromatographic analysis of the basal diet administered to the Group 1 animals contained a chromatographic peak at approximately the same retention time as the test substance and at approximately the same level as that seen in analysis of the quality control (QC) blank samples. This peak was not present in acetonitrile
injections immediately prior to injections of the QC and Group 1 formulation samples, suggesting that the peak was due to an interfering matrix component and not test substance contamination of the control diet formulation. - Duration of treatment / exposure:
- 28 consecutive days
- Frequency of treatment:
- on a continuous basis for 28 consecutive days
- Details on study schedule:
- No mating
Doses / concentrations
- Remarks:
- Doses / Concentrations:
300, 1000, and 10,000 ppm in diet
Basis:
nominal in diet
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, plain diet
- Details on study design:
- - Dose selection rationale: Test substance dietary concentrations were selected by the sponsor based on the results of a prior 14-day dietary range-finding study conducted in this species and strain in which no toxicity or palatability issues were observed at test diet concentrations ≤10,000 ppm.
- Rationale for animal assignment (if not random): computerized randomization procedure
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: at least weekly during the pretest period, throughout the test substance administration period and on the day prior to scheduled necropsy (non-fasted).
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes; recorded weekly during the pretest period and throughout the test substance administration period. Food intake: Yes; g/animal/day for the corresponding body weight intervals
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: mean amounts of C-4000 consumed (mg/kg/day) by each sex per dose group were calculated from the mean food consumed (g/kg/day) and the appropriate target concentration of test substance in the diet (mg/kg)
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: once during the pretest period (study week -1) and near the end of the treatment period (study week 3).
- Dose groups that were examined: all
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at necropsy
- Animals fasted: Yes; overnight
- How many animals: all
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at necropsy
- Animals fasted: Yes; overnight
- How many animals: all
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: during study week 3
- Dose groups that were examined: all
- Battery of functions tested: sensory activity / grip strength / motor activity / other: physiological, home cage, handling, open field - Oestrous cyclicity (parental animals):
- Vaginal lavages were performed for all female animals daily beginning on study day 14
and continuing through the day prior to necropsy. - Sperm parameters (parental animals):
- The following quantitative assessments of the process of spermatogenesis were
performed for all males at the scheduled necropsy:
Motility/viability assessment
Morphology assessment
Enumeration of epididymal and testicular sperm numbers and sperm production rate - Postmortem examinations (parental animals):
- SACRIFICE
- A complete necropsy was conducted for all animals. Animals were euthanized by carbon dioxide anesthesia and exsanguinated.
GROSS NECROPSY
- Gross necropsy consisted of, but were not limited to, examination of the external surface, all orifices, and the cranial, thoracic, abdominal and pelvic cavities, including viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
The following tissues and organs were collected and placed in 10% neutral-buffered formalin (except as noted):
Adrenals (2)
Aorta
Bone with marrow
Femur
Sternum
Bone marrow smear (from
femur) a
Brain
Cerebrum 2 levels
Cerebellum with medulla/pons
Cervix
Epididymides (2) b
Eyes with optic nerve (2) c
Gastrointestinal tract
Esophagus
Stomach
Duodenum
Jejunum
Ileum
Cecum
Colon
Rectum
Heart
Kidneys (2)
Liver (sections of 2 lobes)
Lungs (including bronchi, fixed by
inflation with fixative)
Lymph nodes
Mandibular (2)
Mesenteric
Nasal Cavity d
Ovaries with oviducts (2) e
Pancreas
Peripheral nerve (sciatic)
Peyer’s patches
Pituitary
Prostate
Salivary glands [mandibular (2)]
Seminal vesicles with coagulating
gland (2)
Skeletal muscle (rectus femoris)
Skin (with mammary gland)f
Spinal cord (cervical, thoracic,
lumbar)
Spleen
Testes (2) b
Thymus
Thyroid [with parathyroids, if
present (2)]e
Trachea
Urinary bladder
Uterus
Vagina
Gross lesions (when possible)
a - Not taken from animals found dead, not placed in formalin; not examined.
b - Testis and epididymis (right only) placed in Bouin’s solution.
c - Fixed in Davidson’s solution
d - Levels I and III according to method of Young (Young, 1981) examined
e - Parathyroids and oviducts examined microscopically if in plane of section or if gross lesion present.
f - For females; a corresponding section of skin was taken from the same anatomic area for males.
The following organs were weighed from all animals at the scheduled necropsy:
Adrenals
Brain
Epididymides (total and cauda)*
Heart
Kidneys
Liver
Ovaries with oviducts
Spleen
Testes*
Thymus
Paired organs were weighed together. Designated organs (*) were weighed separately. - Statistics:
- All statistical tests were performed using appropriate computing devices or programs.
Analyses were conducted using two-tailed tests (except as noted otherwise) for minimum significance level 5%, comparing each test substance-treated group to the control group by sex. Each mean was presented with the standard deviation (S.D.), standard error (S.E.) and the number of animals (N) used to calculate the mean. Statistical analyses were not conducted if the number of animals was 2 or less. Due to the use of significant
figures and the different rounding conventions inherent in the types of software used, the means and standard deviations on the summary and individual tables may differ slightly.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- not specified
Details on results (P0)
BODY WEIGHT AND WEIGHT GAIN- unaffected
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)- unaffected
OPHTHALMOSCOPIC EXAMINATION- unaffected
HAEMATOLOGY- unaffected
CLINICAL CHEMISTRY- higher total cholesterol in 10,000 ppm males
NEUROBEHAVIOUR- unaffected
ORGAN WEIGHTS- group mean absolute relative to body liver weights were slightly higher at 10,000 ppm; statistically significant only on a relative basis
GROSS PATHOLOGY- considered to be spontaneous and/or incidental in nature and unrelated to test substance administration
HISTOPATHOLOGY: limited to the liver and thyroid of the 10,000 ppm group males and females:
Microscopic examination of the liver revealed minimal enlargement of centrilobular hepatocytes due to cytoplasmic hypertrophy of a few 10,000 ppm group male and female rats. Minimal or mild hypertrophy and hyperplasia of the follicular epithelial cells of the thyroid was observed in animals of all groups, including the controls, with an increased incidence in the 10,000 ppm group males and females.
OTHER FINDINGS-It is relevant to the evaluations of selected reproductive organ parameters conducted in this study [estrous cycle evaluation in females, and epididymal sperm count, sperm production rate, motility and the percentage of morphologically normal sperm in males] that there were no test substance-related microscopic findings in reproductive organs of males or females in the 300, 1,000 or 10,000 ppm groups.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 10 000 ppm
- Sex:
- male/female
- Basis for effect level:
- other: overall effects
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not examined
- Mortality / viability:
- not examined
- Body weight and weight changes:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- not examined
Details on results (F1)
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- All physiological parameters assessed in this study [estrous cycle evaluation in females, and epididymal sperm count, sperm production rate, motility and the percentage of morphologically normal sperm in males] plus the correlative microscopic findings in reproductive organs of males and females indicated that there were no treatment-related effects on the reproductive organs of males or females in the 300, 1,000 or 10,000 ppm groups.
The results of this study strongly suggests that oral dietary administration of C-4000 at concentration of 10,000 ppm [approximately 723 mg/kg/day for males and 898 mg/kg/day for females] for 28 days is a reproductive NOEL. - Executive summary:
A 28-day repeated dose study vaginal lavages to determine the stage of estrous in females were performed and spermatogenic endpoints in males (motility/viability, morphology, enumeration of epididymal and testicular sperm and sperm production rates) were evaluated.
No adverse effects were observed even at the highest doses of 23 mg/kg/day for males and 898 mg/kg/day for females. There were no signs of mortality or clinical manifestations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Napriek tomu, že agentúra ECHA poskytuje online veľa materiálov vo vašom jazyku, časť tejto stránky je k dispozícii len v anglickom jazyku. Viac informácií o praxi v oblasti viacjazyčnosti v agentúre ECHA.
Internetová stránka agentúry ECHA Stránka nie je plne podporovaná v prehliadači Internet Explorer 7 (a starších verziách). Aktualizujte si prehliadač Internet Explorer na novšiu verziu.
Táto webová lokalita využíva súbory cookies, aby sme vám zabezpečili najlepšie používateľske prostredie na našich webových stránkach.
Viac informácií ako využívame súbory cookies.